These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 20303712
1. Tg.2098 is a major human thyroglobulin T-cell epitope. Menconi F, Huber A, Osman R, Concepcion E, Jacobson EM, Stefan M, David CS, Tomer Y. J Autoimmun; 2010 Aug; 35(1):45-51. PubMed ID: 20303712 [Abstract] [Full Text] [Related]
2. Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease. Li CW, Osman R, Menconi F, Concepcion E, Tomer Y. J Autoimmun; 2020 Mar; 108():102402. PubMed ID: 31980336 [Abstract] [Full Text] [Related]
3. Identifying a Small Molecule Blocking Antigen Presentation in Autoimmune Thyroiditis. Li CW, Menconi F, Osman R, Mezei M, Jacobson EM, Concepcion E, David CS, Kastrinsky DB, Ohlmeyer M, Tomer Y. J Biol Chem; 2016 Feb 19; 291(8):4079-90. PubMed ID: 26703475 [Abstract] [Full Text] [Related]
4. [The role of hereditary and environmental factors in autoimmune thyroid diseases]. Balázs C. Orv Hetil; 2012 Jul 01; 153(26):1013-22. PubMed ID: 22735372 [Abstract] [Full Text] [Related]
5. Effective Inhibition of Thyroid Antigen Presentation Using Retro-Inverso Peptides in Experimental Autoimmune Thyroiditis: A Pathway Toward Immune Therapies of Thyroid Autoimmunity. Li CW, Osman R, Menconi F, Hou H, Schechter C, Kozhakhmetova A, Tomer Y. Thyroid; 2023 Apr 01; 33(4):492-500. PubMed ID: 36762945 [Abstract] [Full Text] [Related]
6. Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis. Kong YC, Brown NK, Flynn JC, McCormick DJ, Brusic V, Morris GP, David CS. J Autoimmun; 2011 Sep 01; 37(2):63-70. PubMed ID: 21683551 [Abstract] [Full Text] [Related]
7. Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes. Li CW, Osman R, Menconi F, Concepcion ES, Tomer Y. J Autoimmun; 2017 Jan 01; 76():1-9. PubMed ID: 27670087 [Abstract] [Full Text] [Related]
8. Human thyroglobulin peptide p2340 induces autoimmune thyroiditis in HLA-DR3 transgenic mice. Karras E, Yang H, Lymberi P, Christadoss P. J Autoimmun; 2005 Jun 01; 24(4):291-6. PubMed ID: 15927791 [Abstract] [Full Text] [Related]
9. Cepharanthine Blocks Presentation of Thyroid and Islet Peptides in a Novel Humanized Autoimmune Diabetes and Thyroiditis Mouse Model. Li CW, Osman R, Menconi F, Faustino LC, Kim K, Clarke OB, Hou H, Tomer Y. Front Immunol; 2021 Jun 01; 12():796552. PubMed ID: 34987519 [Abstract] [Full Text] [Related]
10. Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice. Flynn JC, Meroueh C, Snower DP, David CS, Kong YM. Clin Exp Immunol; 2007 Mar 01; 147(3):547-54. PubMed ID: 17302906 [Abstract] [Full Text] [Related]
11. Delineation of five thyroglobulin T cell epitopes with pathogenic potential in experimental autoimmune thyroiditis. Verginis P, Stanford MM, Carayanniotis G. J Immunol; 2002 Nov 01; 169(9):5332-7. PubMed ID: 12391254 [Abstract] [Full Text] [Related]
12. HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible. Wan Q, Shah R, Panos JC, Giraldo AA, David CS, Kong Yc. Hum Immunol; 2002 Apr 01; 63(4):301-10. PubMed ID: 12039412 [Abstract] [Full Text] [Related]
13. A Novel Mouse Model of Autoimmune Thyroiditis Induced by Immunization with Adenovirus Containing Full-Length Thyroglobulin cDNA: Implications to Genetic Studies of Thyroid Autoimmunity. Faustino LC, Li CW, Stefan-Lifshitz M, Kim K, Clarke OB, Tomer Y. Thyroid; 2020 Sep 01; 30(9):1338-1345. PubMed ID: 32228171 [Abstract] [Full Text] [Related]
14. Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in nonobese diabetic mice. Flynn JC, Fuller BE, Giraldo AA, Panos JC, David CS, Kong YC. J Autoimmun; 2001 Aug 01; 17(1):7-15. PubMed ID: 11488633 [Abstract] [Full Text] [Related]
15. Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Flynn JC, McCormick DJ, Brusic V, Wan Q, Panos JC, Giraldo AA, David CS, Kong YC. Cell Immunol; 2004 Jun 01; 229(2):79-85. PubMed ID: 15474522 [Abstract] [Full Text] [Related]
16. Coexpression of susceptible and resistant HLA class II transgenes in murine experimental autoimmune thyroiditis: DQ8 molecules downregulate DR3-mediated thyroiditis. Flynn JC, Wan Q, Panos JC, McCormick DJ, Giraldo AA, David CS, Kong YC. J Autoimmun; 2002 May 01; 18(3):213-20. PubMed ID: 12126634 [Abstract] [Full Text] [Related]
17. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease. Kong YC, Flynn JC, Wan Q, David CS. Autoimmunity; 2003 May 01; 36(6-7):397-404. PubMed ID: 14669947 [Abstract] [Full Text] [Related]
18. Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice. Flynn JC, Gardas A, Wan Q, Gora M, Alsharabi G, Wei WZ, Giraldo AA, David CS, Kong YM, Banga JP. Clin Exp Immunol; 2004 Sep 01; 137(3):503-12. PubMed ID: 15320899 [Abstract] [Full Text] [Related]
19. Mapping of thyroglobulin epitopes: presentation of a 9mer pathogenic peptide by different mouse MHC class II isotypes. Rao VP, Balasa B, Carayanniotis G. Immunogenetics; 1994 Sep 01; 40(5):352-9. PubMed ID: 7927539 [Abstract] [Full Text] [Related]
20. Application of HLA class II transgenic mice to study autoimmune regulation. Kong YC, Flynn JC, Banga JP, David CS. Thyroid; 2007 Oct 01; 17(10):995-1003. PubMed ID: 17900224 [Abstract] [Full Text] [Related] Page: [Next] [New Search]